Active Ingredient(s): Clofazimine
FDA Approved: * December 15, 1986
Pharm Company: * NOVARTIS
Category: Leprosy

Clofazimine, sold under the brand name Lamprene, is a medication used together with rifampicin and dapsone to treat leprosy.[1] It is specifically used for multibacillary (MB) leprosy and erythema nodosum leprosum.[2] Evidence is insufficient to support its use in other conditions[1] though a retrospective study found it 95% effective in the treatment of Mycobacterium avium complex (MAC) when administered with a macrolide and ethambutol,[... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.